Arvinas, Inc. (ARVN)
9.08
-0.34
(-3.61%)
USD |
NASDAQ |
May 15, 16:00
9.10
+0.02
(+0.22%)
After-Hours: 20:00
Arvinas Research and Development Expense (Quarterly) : 60.00M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.452B |
| Rigel Pharmaceuticals, Inc. | 11.68M |
| EyePoint, Inc. | 72.15M |
| Elanco Animal Health, Inc. | 97.00M |
| Corcept Therapeutics, Inc. | 66.26M |